First Interstate Bank Omeros Corp Transaction History

First Interstate Bank

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 11, 2020	SELL	$9.03 - $19.72 $22,575 - $49,300	-2,500 Closed	0 $0
Q4 2019 Feb 06, 2020	SELL	$13.01 - $17.15 $32,525 - $42,875	-2,500 Reduced 50.0%	2,500 $35,000
Q4 2018 Jan 31, 2019	SELL	$10.72 - $16.73 $53,600 - $83,650	-5,000 Reduced 50.0%	5,000 $56,000
Q3 2018 Nov 07, 2018	BUY	$17.73 - $26.69 $88,650 - $133,450	5,000 Added 100.0%	10,000 $244,000
Q3 2017 Nov 08, 2017	BUY	$19.76 - $24.9 $98,800 - $124,500	5,000	5,000 $108,000

120

25.6M

228K

630K

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $762M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

Get notified when there are updates to the investment portfolio of First Interstate Bank, based on Form 13F filings with the SEC.

Stay updated on First Interstate Bank with notifications on news.